AGP Picks
View all

Pulmolite market seen growing on respiratory disease demand

Nov. 10, 2026
Pulmolite market seen growing on respiratory disease demand
By AI, Created 00:15 UTC, Nov 10, 2026, AGP -

The Pulmolite market is expanding as nuclear medicine, diagnostic imaging and respiratory disease diagnosis gain traction worldwide. North America led the market in 2025, while Asia-Pacific is expected to grow fastest through the forecast period.

Why it matters: - Pulmolite is used in lung perfusion scans to help diagnose pulmonary embolism and assess lung function before surgery. - Demand is rising as healthcare systems expand nuclear medicine capabilities and seek more accurate pulmonary diagnostics. - Growth in respiratory illness, air pollution and healthcare spending is reinforcing the need for diagnostic radiopharmaceuticals.

What happened: - The Business Research Company published an updated competitive landscape review of the Pulmolite market on Nov. 10, 2026. - The report said the market grew in the past on the back of expanding nuclear medicine infrastructure, more pulmonary embolism diagnoses and broader use of technetium-based imaging agents. - The report also pointed to hospital imaging service growth and regulatory approvals for radiopharmaceuticals as supporting demand. - The market is projected to keep growing as outpatient diagnostic centers expand and nuclear medicine facilities receive more investment. - A free sample of the report is available through the company's sample request page. - The full report is available through the company's market report page.

The details: - Pulmolite contains technetium-99m-labeled particles that are injected into the bloodstream and accumulate in the lungs for imaging. - The agent helps clinicians evaluate blood flow within the lungs and identify lung function issues. - The report said rising respiratory disorders are a major market driver. - In June 2024, the Australian Institute of Health and Welfare reported about 8.5 million people in Australia, or 34% of the population, had chronic respiratory diseases. - The same data set included about 2.8 million people with asthma and 638,000 with chronic obstructive pulmonary disease. - Higher healthcare spending is also supporting the market by improving access to organ preservation and lung transplantation technologies. - In May 2024, the UK Office for National Statistics reported total healthcare expenditure rose 5.6% nominally from 2022 to 2023. - The Office for National Statistics also said long-term health and social care spending rose 2.8% in real terms in 2022. - Air pollution is adding to demand because Pulmolite can help evaluate lung damage linked to polluted air. - In August 2024, the US Environmental Protection Agency said about 66 million tons of pollutants were released into the atmosphere in the United States during 2023. - In 2025, North America held the largest share of the Pulmolite market. - Asia-Pacific is expected to be the fastest-growing region through the forecast period. - The report covers Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East and Africa.

Between the lines: - The market story is less about one product and more about the spread of imaging infrastructure, diagnostics spending and chronic disease burden. - The forecast implies growth will likely track both medical capacity and environmental health pressures. - The report's added strategic tools, including TAM analysis, company scoring matrices and dashboards, suggest the market is being positioned for competitive benchmarking as much as size estimation.

What's next: - The report expects continued growth from advances in nuclear imaging technology and improved radiotracer stability. - The market should benefit from more lung perfusion scans and broader use of radiopharmaceuticals in diagnostic imaging. - Early and precise respiratory disease detection is likely to remain a key demand driver. - The Business Research Company said its 2026 reports now include market attractiveness scoring, TAM analysis, company scoring matrix graphics and tables, Excel-based dashboards, market hotspots infographics and updated trend analysis.

The bottom line: - Pulmolite demand is tied to a mix of clinical need, imaging capacity and environmental health trends, with North America leading now and Asia-Pacific positioned for the fastest growth.

Disclaimer: This article was produced by AGP Wire with the assistance of artificial intelligence based on original source content and has been refined to improve clarity, structure, and readability. This content is provided on an “as is” basis. While care has been taken in its preparation, it may contain inaccuracies or omissions, and readers should consult the original source and independently verify key information where appropriate. This content is for informational purposes only and does not constitute legal, financial, investment, or other professional advice.

Sign up for:

UK Post Observer

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

UK Post Observer

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.